AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10718887 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (structured feedback programme)
Number of subjects: 47
Study 10718887 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 47
Study 8667172 — intervention group
Group type: EXPERIMENTAL
Intervention: Rejection-sensitive individuals
Number of subjects: 0
Study 8667172 — intervention group
Group type: EXPERIMENTAL
Intervention: Rejection-sensitive men's jealousy
Number of subjects: 0
Study 8667172 — intervention group
Group type: EXPERIMENTAL
Intervention: Rejection-sensitive women's hostility and diminished supportiveness
Number of subjects: 0
Study 1399560 — intervention group
Group type: EXPERIMENTAL
Intervention: 10mg of flunarizine per day
Number of subjects: 40
Study 1399560 — intervention group
Group type: EXPERIMENTAL
Intervention: 3mg of flunarizine per day
Number of subjects: 40
Study 6379789 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenoterol (200 μg) administered by pressurized aerosol
Number of subjects: 14
Study 6379789 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenoterol (200 μg) administered in powder form
Number of subjects: 14
Study 6379789 — intervention group
Group type: COMPARATOR
Intervention: Overall evaluation of both formulations
Number of subjects: 14
Study 30798790 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-level stepped care intervention
Number of subjects: 0
Study 29564773 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D robotic system with error-augmenting forces
Number of subjects: 41
Study 29564773 — intervention group
Group type: COMPARATOR
Intervention: Null-field conditions (control group)
Number of subjects: 41
Study 27001281 — intervention group
Group type: EXPERIMENTAL
Intervention: Test breakfast (lower carbohydrate, higher fat and protein content)
Number of subjects: 20
Study 27001281 — intervention group
Group type: COMPARATOR
Intervention: Reference breakfast (traditional breakfast)
Number of subjects: 20
Study 25494175 — intervention group
Group type: EXPERIMENTAL
Intervention: Soccer
Number of subjects: 107
Study 25494175 — intervention group
Group type: EXPERIMENTAL
Intervention: Zumba
Number of subjects: 107
Study 25494175 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 107
Study 22286927 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose CT screening
Number of subjects: 4104
Study 22286927 — intervention group
Group type: COMPARATOR
Intervention: No screening (control)
Number of subjects: 4104
Study 20942920 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic feedback intervention
Number of subjects: 0
Study 20942920 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual feedback on task performance
Number of subjects: 0
Study 17344602 — intervention group
Group type: EXPERIMENTAL
Intervention: End-tidal isoflurane concentration 0.6 MAC (Group I1)
Number of subjects: 40
Study 17344602 — intervention group
Group type: EXPERIMENTAL
Intervention: End-tidal isoflurane concentration 1.0 MAC (Group I2)
Number of subjects: 40
Study 17344602 — intervention group
Group type: EXPERIMENTAL
Intervention: Endotracheal intubation stimulation
Number of subjects: 40
Study 17344602 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin incision and exploration stimulation
Number of subjects: 40
Study 15685517 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil
Number of subjects: 16
Study 15685517 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 11515717 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 mg tablet of aqueous extract of Uncaria tomentosa (C‐Med‐100)
Number of subjects: 12
Study 11515717 — intervention group
Group type: EXPERIMENTAL
Intervention: 350 mg tablet of aqueous extract of Uncaria tomentosa (C‐Med‐100)
Number of subjects: 12
Study 11515717 — intervention group
Group type: COMPARATOR
Intervention: Non-supplemented controls
Number of subjects: 12
Study 9721000 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral arm or leg training
Number of subjects: 39
Study 9721000 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral arm or leg training
Number of subjects: 39
Study 9721000 — intervention group
Group type: EXPERIMENTAL
Intervention: Untrained limbs (unilateral training)
Number of subjects: 39
Study 9721000 — intervention group
Group type: EXPERIMENTAL
Intervention: Untrained limbs (bilateral training)
Number of subjects: 39
Study 9721000 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 39
Study 9721000 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral index (BI) in trained limbs of bilateral training group
Number of subjects: 39
Study 9721000 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral index (BI) in trained limbs of unilateral training group
Number of subjects: 39
Study 9721000 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral index (BI) in untrained limbs of unilateral training group
Number of subjects: 39
Study 9721000 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral index (BI) in untrained limbs of bilateral training group
Number of subjects: 39
Study 7838462 — intervention group
Group type: EXPERIMENTAL
Intervention: Mantle field radiotherapy
Number of subjects: 71
Study 7838462 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.4% stannous fluoride 'brush-in' technique
Number of subjects: 71
Study 7838462 — intervention group
Group type: COMPARATOR
Intervention: Preradiotherapy group
Number of subjects: 71
Study 3421258 — intervention group
Group type: EXPERIMENTAL
Intervention: Preterm labor education, frequent (5 days/week) telephone contact, and self‐palpation of uterine activity (group EP)
Number of subjects: 266
Study 3421258 — intervention group
Group type: EXPERIMENTAL
Intervention: Preterm labor education, daily telephone contact, and the Term Guard ambulatory uterine activity monitor (group EM)
Number of subjects: 266
Study 3421258 — intervention group
Group type: COMPARATOR
Intervention: All subjects enrolled in year 1
Number of subjects: 266
Study 3421258 — intervention group
Group type: COMPARATOR
Intervention: All subjects enrolled in year 2
Number of subjects: 266
Study 29981817 — intervention group
Group type: EXPERIMENTAL
Intervention: Umbilical cord milking
Number of subjects: 60
Study 29981817 — intervention group
Group type: COMPARATOR
Intervention: No milking
Number of subjects: 60
Study 28846600 — intervention group
Group type: EXPERIMENTAL
Intervention: LTLT-cooked roast, 58 °C, 72 min
Number of subjects: 37
Study 28846600 — intervention group
Group type: EXPERIMENTAL
Intervention: LTLT-cooked roast, 58 °C, 17 h
Number of subjects: 37
Study 28846600 — intervention group
Group type: EXPERIMENTAL
Intervention: Oven-cooked roast, 160 °C
Number of subjects: 37
Study 28846600 — intervention group
Group type: EXPERIMENTAL
Intervention: LTLT-cooked minced patties, 58 °C, 17 h
Number of subjects: 37
Study 28846600 — intervention group
Group type: EXPERIMENTAL
Intervention: LTLT cooking for 72 min
Number of subjects: 37
Study 28846600 — intervention group
Group type: EXPERIMENTAL
Intervention: LTLT cooking for 17 h
Number of subjects: 37
Study 28846600 — intervention group
Group type: EXPERIMENTAL
Intervention: Oven cooking
Number of subjects: 37
Study 25510746 — intervention group
Group type: EXPERIMENTAL
Intervention: Pitavastatin 2 mg
Number of subjects: 60
Study 25510746 — intervention group
Group type: COMPARATOR
Intervention: Pravastatin 20 mg
Number of subjects: 60
Study 25510746 — intervention group
Group type: EXPERIMENTAL
Intervention: SES with LDL cholesterol < 70 mg/dL
Number of subjects: 60
Study 25510746 — intervention group
Group type: EXPERIMENTAL
Intervention: BES
Number of subjects: 60
Study 23186613 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose-rate intraluminal brachytherapy (ILBT) through percutaneous transhepatic biliary drainage (PTBD)
Number of subjects: 18
Study 21036778 — intervention group
Group type: EXPERIMENTAL
Intervention: BNP-guided diagnostic strategy
Number of subjects: 314
Study 21036778 — intervention group
Group type: COMPARATOR
Intervention: Standard diagnostic strategy
Number of subjects: 314
Study 19044214 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine IR 150 mg
Number of subjects: 32
Study 19044214 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 17699248 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous iron sucrose (1 g total, divided into 300 mg over 1.5 h on days 1 and 15, and 400 mg over 2.5 h on day 29)
Number of subjects: 96
Study 17699248 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous iron sucrose
Number of subjects: 96
Study 17699248 — intervention group
Group type: COMPARATOR
Intervention: Control (no supplemental iron)
Number of subjects: 96
Study 12828803 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive therapy (CT) for depression
Number of subjects: 58
Study 10554841 — intervention group
Group type: EXPERIMENTAL
Intervention: Tight fundoplication (group A)
Number of subjects: 16
Study 10554841 — intervention group
Group type: COMPARATOR
Intervention: Normal fundoplication (group B)
Number of subjects: 16
Study 8764308 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucrose polyester (SPE) - 52 g of fat replaced, 3.1 MJ, 740 kcal
Number of subjects: 95
Study 8764308 — intervention group
Group type: COMPARATOR
Intervention: Normal dietary fat - 5.0 MJ, 1,195 kcal
Number of subjects: 95
Study 8764308 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucrose polyester (SPE)
Number of subjects: 95
Study 1865045 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (35.33 mg/day)
Number of subjects: 46
Study 1865045 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 6345421 — intervention group
Group type: EXPERIMENTAL
Intervention: Triiodothyronine supplementation (50 micrograms, 3 times daily)
Number of subjects: 18
Study 6345421 — intervention group
Group type: COMPARATOR
Intervention: Control group (Gp B)
Number of subjects: 18
Study 31209630 — intervention group
Group type: EXPERIMENTAL
Intervention: Scrambler Therapy
Number of subjects: 50
Study 31209630 — intervention group
Group type: COMPARATOR
Intervention: Transcutaneous Electrical Nerve Stimulation (TENS)
Number of subjects: 50
Study 31209630 — intervention group
Group type: COMPARATOR
Intervention: TENS
Number of subjects: 50
Study 28409566 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined administration of yohimbine (α2-adrenergic antagonist) and hydrocortisone
Number of subjects: 0
Study 28409566 — intervention group
Group type: COMPARATOR
Intervention: Hydrocortisone
Number of subjects: 0
Study 28409566 — intervention group
Group type: COMPARATOR
Intervention: Yohimbine
Number of subjects: 0
Study 28409566 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 27336209 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 644
Study 27336209 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Letrozole and Berberine
Number of subjects: 644
Study 27336209 — intervention group
Group type: COMPARATOR
Intervention: Berberine
Number of subjects: 644
Study 24942888 — intervention group
Group type: EXPERIMENTAL
Intervention: NDC intervention areas
Number of subjects: 0
Study 24942888 — intervention group
Group type: COMPARATOR
Intervention: HSE high deprivation areas
Number of subjects: 0
Study 22938660 — intervention group
Group type: EXPERIMENTAL
Intervention: SCysCAC formula
Number of subjects: 96
Study 22938660 — intervention group
Group type: EXPERIMENTAL
Intervention: Arnal-Dade formula
Number of subjects: 96
Study 22938660 — intervention group
Group type: EXPERIMENTAL
Intervention: Larsson formula
Number of subjects: 96
Study 22938660 — intervention group
Group type: EXPERIMENTAL
Intervention: Rule formula
Number of subjects: 96
Study 20865875 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated intermittent bolus (2.5 ml every 15 minutes)
Number of subjects: 50
Study 20865875 — intervention group
Group type: COMPARATOR
Intervention: Continuous epidural infusion (10 ml/hour)
Number of subjects: 50
Study 18441457 — intervention group
Group type: EXPERIMENTAL
Intervention: Betaxolol adding group
Number of subjects: 65
Study 18441457 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine dose‐up group
Number of subjects: 65
Study 15915547 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril 10 mg
Number of subjects: 9
Study 15915547 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 12783344 — intervention group
Group type: EXPERIMENTAL
Intervention: HPCP stent
Number of subjects: 100
Study 12783344 — intervention group
Group type: COMPARATOR
Intervention: PE stent
Number of subjects: 100
Study 10606114 — intervention group
Group type: EXPERIMENTAL
Intervention: 60% inspired oxygen concentration
Number of subjects: 16
Study 10606114 — intervention group
Group type: COMPARATOR
Intervention: 21% inspired oxygen concentration
Number of subjects: 16
Study 7813271 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirbuterol
Number of subjects: 26
Study 7813271 — intervention group
Group type: COMPARATOR
Intervention: Ipratropium
Number of subjects: 26
Study 1683340 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg zotepine
Number of subjects: 15
Study 1683340 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg zotepine
Number of subjects: 15
Study 1683340 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg zotepine
Number of subjects: 15
Study 1683340 — intervention group
Group type: COMPARATOR
Intervention: 50 mg clozapin (reference substance)
Number of subjects: 15
Study 6114503 — intervention group
Group type: EXPERIMENTAL
Intervention: fluphenazine enanthate
Number of subjects: 59
Study 6114503 — intervention group
Group type: EXPERIMENTAL
Intervention: pipothiazine palmitate IM
Number of subjects: 59
Study 6114503 — intervention group
Group type: COMPARATOR
Intervention: therapy responders
Number of subjects: 59
Study 6114503 — intervention group
Group type: COMPARATOR
Intervention: therapy non-responders
Number of subjects: 59
Study 6146272 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfentanil (6 micrograms/kg)
Number of subjects: 0
Study 6146272 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 0
Study 31859791 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual zolpidem 5 mg
Number of subjects: 67
Study 31859791 — intervention group
Group type: COMPARATOR
Intervention: Oral zolpidem 10 mg
Number of subjects: 67
Study 29578880 — intervention group
Group type: EXPERIMENTAL
Intervention: Solifenacin 5 mg + Mirabegron 50 mg (combination 5+50 mg)
Number of subjects: 715
Study 29578880 — intervention group
Group type: EXPERIMENTAL
Intervention: Solifenacin 5 mg + Mirabegron 25 mg (combination 5+25 mg)
Number of subjects: 715
Study 29578880 — intervention group
Group type: EXPERIMENTAL
Intervention: Solifenacin 5 mg
Number of subjects: 715
Study 29578880 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirabegron 50 mg
Number of subjects: 715
Study 29578880 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirabegron 25 mg
Number of subjects: 715
Study 29578880 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 715
Study 27222162 — intervention group
Group type: EXPERIMENTAL
Intervention: Child Health Initiative for Lifelong Eating and Exercise (CHILE) intervention, which included a classroom curriculum, teacher and food service training, family engagement, grocery store participation, and healthcare provider support.
Number of subjects: 1898
Study 27222162 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (control)
Number of subjects: 1898
Study 23925451 — intervention group
Group type: EXPERIMENTAL
Intervention: D-dimer levels ≥ 0.71 μg/mL on admission
Number of subjects: 461
Study 23925451 — intervention group
Group type: EXPERIMENTAL
Intervention: D-dimer levels ≥ 1.26 μg/mL at discharge
Number of subjects: 461
Study 22159967 — intervention group
Group type: EXPERIMENTAL
Intervention: Harmonic scalpel
Number of subjects: 144
Study 22159967 — intervention group
Group type: COMPARATOR
Intervention: Bipolar dissection
Number of subjects: 144
Study 20642660 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental Analgesia Slide
Number of subjects: 160
Study 18335328 — intervention group
Group type: EXPERIMENTAL
Intervention: Myo-inositol 2 gr. plus folic acid 200 mug every day
Number of subjects: 20
Study 18335328 — intervention group
Group type: COMPARATOR
Intervention: Folic acid 200 mug every day
Number of subjects: 20
Study 16199243 — intervention group
Group type: EXPERIMENTAL
Intervention: RBX 64 mg/d
Number of subjects: 205
Study 16199243 — intervention group
Group type: EXPERIMENTAL
Intervention: RBX 32 mg/d
Number of subjects: 205
Study 16199243 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 205
Study 12456132 — intervention group
Group type: EXPERIMENTAL
Intervention: Community Activities intervention
Number of subjects: 0
Study 12456132 — intervention group
Group type: EXPERIMENTAL
Intervention: Mammography promotion
Number of subjects: 0
Study 12456132 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual counseling and combined intervention
Number of subjects: 0
Study 10500005 — intervention group
Group type: EXPERIMENTAL
Intervention: Baclofen (10 mg three times daily for 14 days)
Number of subjects: 6
Study 10500005 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 8961085 — intervention group
Group type: EXPERIMENTAL
Intervention: Ephedrine (50 mg, two doses with a 4‐h interval)
Number of subjects: 12
Study 8961085 — intervention group
Group type: EXPERIMENTAL
Intervention: Moclobemide (300 mg b.i.d.)
Number of subjects: 12
Study 8961085 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 2012398 — intervention group
Group type: EXPERIMENTAL
Intervention: Induced hypertension chemotherapy (IHC) using angiotensin II human in 8 patients.
Number of subjects: 13
Study 2012398 — intervention group
Group type: COMPARATOR
Intervention: Conventional chemotherapy in 5 patients (5‐fluorouracil, adriamycin, mitomycin C).
Number of subjects: 13
Study 6957983 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirenzepine (50 mgs orally)
Number of subjects: 6
Study 6957983 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 31299061 — intervention group
Group type: EXPERIMENTAL
Intervention: WALK (3-min moderate-intensity walk every 30-min)
Number of subjects: 11
Study 31299061 — intervention group
Group type: COMPARATOR
Intervention: SIT (remained seated for 5 hours)
Number of subjects: 11
Study 27509544 — intervention group
Group type: EXPERIMENTAL
Intervention: Gadoxetate disodium
Number of subjects: 44
Study 27509544 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 44
Study 27509544 — intervention group
Group type: COMPARATOR
Intervention: Gadoterate meglumine
Number of subjects: 44
Study 25583852 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensory integration balance training (experimental group, n = 39)
Number of subjects: 80
Study 25583852 — intervention group
Group type: COMPARATOR
Intervention: Conventional rehabilitation (control group, n = 41)
Number of subjects: 80
Study 23899638 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 30
Study 23899638 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 30
Study 23899638 — intervention group
Group type: EXPERIMENTAL
Intervention: Ziprasidone
Number of subjects: 30
Study 23899638 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone, Olanzapine, Ziprasidone
Number of subjects: 30
Study 20953579 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training
Number of subjects: 251
Study 20953579 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined training (aerobic + resistance)
Number of subjects: 251
Study 20953579 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise
Number of subjects: 251
Study 20953579 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic plus resistance exercise
Number of subjects: 251
Study 20953579 — intervention group
Group type: COMPARATOR
Intervention: Sedentary control group
Number of subjects: 251
Study 19909588 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH agonist (0.2 mg of triptorelin)
Number of subjects: 100
Study 19909588 — intervention group
Group type: COMPARATOR
Intervention: Recombinant HCG (250 microg)
Number of subjects: 100
Study 17213972 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium chondroitin sulphate (Uropol S)
Number of subjects: 82
Study 17213972 — intervention group
Group type: COMPARATOR
Intervention: Anticholinergic agent (tolterodine)
Number of subjects: 82
Study 12911553 — intervention group
Group type: EXPERIMENTAL
Intervention: Azathioprine
Number of subjects: 128
Study 12911553 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporine
Number of subjects: 128
Study 11760898 — intervention group
Group type: EXPERIMENTAL
Intervention: Transanal endoscopic microsurgery (TEM)
Number of subjects: 33
Study 9396886 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction with oxytocin
Number of subjects: 0
Study 9396886 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction with prostaglandin
Number of subjects: 0
Study 9396886 — intervention group
Group type: EXPERIMENTAL
Intervention: Expectant management
Number of subjects: 0
Study 9396886 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction with oxytocin or prostaglandin if failed
Number of subjects: 0
Study 9396886 — intervention group
Group type: EXPERIMENTAL
Intervention: Number of digital vaginal examinations > 8
Number of subjects: 0
Study 9396886 — intervention group
Group type: EXPERIMENTAL
Intervention: Number of digital vaginal examinations 7 to 8
Number of subjects: 0
Study 9396886 — intervention group
Group type: EXPERIMENTAL
Intervention: Number of digital vaginal examinations 5 to 6
Number of subjects: 0
Study 9396886 — intervention group
Group type: EXPERIMENTAL
Intervention: Number of digital vaginal examinations 3 to 4
Number of subjects: 0
Study 9396886 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of active labor >= 12 hours
Number of subjects: 0
Study 9396886 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of active labor 9 to < 12 hours
Number of subjects: 0
Study 9396886 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of active labor 6 to < 9 hours
Number of subjects: 0
Study 9396886 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of active labor 2 to < 6 hours
Number of subjects: 0
Study 9396886 — intervention group
Group type: EXPERIMENTAL
Intervention: Meconium-stained amniotic fluid
Number of subjects: 0
Study 9396886 — intervention group
Group type: EXPERIMENTAL
Intervention: Parity of 0
Number of subjects: 0
Study 9396886 — intervention group
Group type: EXPERIMENTAL
Intervention: Time from membrane rupture to active labor >= 48 hours
Number of subjects: 0
Study 9396886 — intervention group
Group type: EXPERIMENTAL
Intervention: Time from membrane rupture to active labor 24 to < 48 hours
Number of subjects: 0